Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since results from one of the first clinical trials of such a therapeutic approach in patients with NSCLC were reported in 2018 (ref. 19), the efficacy and safety of neoadjuvant ICIs have been firmly established in multiple tumour types, with FDA approvals for two indications (NSCLC20,120 and triple-negative breast cancer8).”
From Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024) · cites this paper as [19]
Citations
Cites
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1703481 · Cited by 4,849
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Socinski, M. A., Jotte, R. M., Cappuzzo, F., Orlandi, F., Stroyakovskiy, D., Nogami, N., Rodríguez-Abreu, D., Moro-Sibilot, D., Thomas, C. A., Barlesi, F., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716948 · Cited by 3,733
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Seymour, L., Bogaerts, J., Perrone, A., Ford, R., Schwartz, L. H., Mandrekar, S., Lin, N. U., Litière, S., Dancey, J., Chen, A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30074-8 · Cited by 2,472
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Forde, P. M., Chaft, J. E., Smith, K. N., Anagnostou, V., Cottrell, T. R., Hellmann, M. D., Zahurak, M., Yang, S. C., Jones, D. R., Broderick, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716078 · Cited by 2,099
Gainor, J. F., Shaw, A. T., Sequist, L. V., Fu, X., Azzoli, C. G., Piotrowska, Z., Huynh, T. G., Zhao, L., Fulton, L., Schultz, K. R., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3101 · Cited by 1,250
(2017) · doi:10.1158/1078-0432.ccr-16-3133 · Cited by 831
Signaling Through OX40 Enhances Antitumor Immunity
Jensen, S. M., Maston, L. D., Gough, M. J., Ruby, C. E., Redmond, W. L., Crittenden, M., Li, Y., Puri, S., Poehlein, C. H., Morris, N., et al. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.09.013 · Cited by 146
Imbalance of dendritic cell co-stimulation in COPD
Stoll, P., Ulrich, M., Bratke, K., Garbe, K., Virchow, J. C., Jr., & Lommatzsch, M. (2015) · Respiratory Research · doi:10.1186/s12931-015-0174-x · Cited by 36
Cited by
Items 201–291 of 291
Gan, Y., Liu, Z., Tang, Z., Yao, X., Zeng, B., & Zhu, H. (2023) · Oncology Letters · doi:10.3892/ol.2023.14133 · Cited by 5
Wang, Y., Sun, Y., Hu, J., & Ma, H. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s495449 · Cited by 3
Shiraishi, Y., Terakawa, T., Jimbo, N., Shigemura, K., Hinata, N., & Fujisawa, M. (2018) · International Journal of Urology · doi:10.1111/iju.13853 · Cited by 3
Saman, H. T., Shahab Uddin, M. S., Raza, S. S., Shrimali, R. K., & Rasul, K. I. (2020) · Clinical Oncology and Research · doi:10.31487/j.cor.2020.09.08 · Cited by 3
Cohen, E., Wang, D., Engle, E. M., Green, B., Caushi, J. X., Zhang, J., Sunshine, J. C., Uttam, S., Fotheringham, M., Fiorante, A., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-sitc2022.0057 · Cited by 3
Yuan, F., Jiang, Y., Zhou, Y., Li, Z., Yang, Q.-Q., Mo, J.-F., Wen, Y.-Y., & Shen, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19155 · Cited by 2
“The clinical result of advanced stage NSCLC has remained unsatisfactory in recent years, despite the enormous advancements made in surgery, immunotherapy, chemotherapy, and radiotherapy, which significantly improved the prognosis of NSCLC [4].”
Aicher, A., Rekhtman, D., Eisinger, E. C., Niemeyer, E., Davis, C. W., Haas, A., Nichols, W. G., Aguilar, L. K., Aguilar-Córdova, E., Kucharczuk, J. C., et al. (2025) · JTCVS Open · doi:10.1016/j.xjon.2025.10.032 · Cited by 2
Park, J. H., Park, Y. M., Kim, D., Kim, S., Kim, H. R., & Koh, Y. W. (2022) · Korean Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.3342/kjorl-hns.2022.00283 · Cited by 3
Prognostic characteristics of T-cell mediated cell killing-related genes in lung adenocarcinoma
Bi, L., Ai, C., Zhang, H., Chen, Z., Deng, Y., Xiong, J., & Lv, Z. (2023) · Autoimmunity · doi:10.1080/08916934.2023.2250097 · Cited by 2
Guo, J., Lin, S.-D., Minervini, F., Geraci, T. C., Kim, J. J., Tong, C.-Y., Li, X., & Cao, C. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1175 · Cited by 2
Sekine, I., Aida, Y., & Suzuki, H. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.09.91 · Cited by 2
Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy?
Zhang, Z., Lin, J., & Kang, M. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.11.38 · Cited by 2
Alveolar macrophages in patients with non-small cell lung cancer.
Li, J., Li, J., Wang, L., Hao, J., Wu, L., Tao, H., Zhang, S., Cui, P., Li, L. X., Zhang, X., et al. (2020) · PubMed Central · Cited by 2
Zhang, H., Liu, M., Yang, Z., Du, G., Yu, B., Gui, Y., Cao, L., Li, X., & Tan, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-16715-0 · Cited by 2
Wang, H., Gu, D., Chen, D., Mei, J., Yang, X., Ding, J., Xu, J., Wang, M., Liu, C., & Hua, D. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s381530 · Cited by 2
Self-citationWang, Y., Song, Y., Wang, R., Wu, Y., Li, M., Xu, K., He, R., Wang, Z., Li, Q., Kong, F., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1265228 · Cited by 2
Donington, J. S. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-11915-4 · Cited by 2
Lee, C., DiNatale, R. G., Chowell, D., Krishna, C., Makarov, V., Valero, C., Vuong, L. H., Lee, M., Weiss, K. L., Hoen, D., et al. (2023) · doi:10.1158/1541-7786.c.6545243 · Cited by 2
Leopizzi, M., Pernazza, A., Rullo, E., Cerbelli, B., Pisano, A., Anile, M., Gelibter, A. J., Rughetti, A., Bassi, M., Nuti, M., et al. (2025) · International Journal of Clinical and Experimental Pathology · doi:10.62347/ncyz7977 · Cited by 1
HLA-I genotype landscape in lung cancer and its prognosis value in Chinese small cell lung cancer
Zhao, J., Dong, B., Wang, Z., Wang, B., Yan, C. W., Li, X., Guo, Y., & Du, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-18839-5 · Cited by 1
Indini, A., Rijavec, E., Bareggi, C., & Grossi, F. (2021) · Current Challenges in Thoracic Surgery · doi:10.21037/ccts-20-69 · Cited by 1
Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer
Lim, J. U., & Kang, H. S. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-764 · Cited by 1
Qu, Y., Wang, C., Liu, L., Li, S., Zhang, X., Ma, Z., Bai, H., & Wang, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728647 · Cited by 1
Söyler, Y., & Yılmaz, Ü. (2021) · AME Surgical Journal · doi:10.21037/asj-21-75 · Cited by 1
Cancer Biomarkers and Targets in Digestive Organs
Yee, N. S., & Lee, N. P. Y. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-464-8 · Cited by 1
Specialist In Family And Community Medicine, C. D. S. T. A., Reinoso, G. P. G., Moscoso, N. P. C., Physician, U. C. D. E., Goyo, P. D. A., Physician, U. D. C., Rodríguez, B. S. P., Physician, U. D. L. A., Muñoz, J. V. U., & Physician, U. D. G. (2024) · International Journal of Medical Science and Dental Health · doi:10.55640/ijmsdh-10-02-16 · Cited by 1
Pardo, D., Viola, L., Zuluaga, J. A., Rojas, L., Bobadilla, I., Martínez, S., Bustillo, I., García-Herreros, L. G., Zapata, R., Serna, A., et al. (2023) · Medicina · doi:10.56050/01205498.2316 · Cited by 2
Chen, C., Pei, L., Ren, W., & Sun, J. (2024) · Medicine · doi:10.1097/md.0000000000040820 · Cited by 2
Ma, X., Li, B., Li, Y., Lu, L., & Chen, H. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.12.025 · Cited by 1
Lücke, E., Ganzert, C., Föllner, S., Wäsche, A., Jechorek, D., Schoeder, V., Walles, T., Genseke, P., & Schreiber, J. (2020) · TumorDiagnostik & Therapie · doi:10.1055/a-1294-7413 · Cited by 1
“[19] veröffentlichen Daten einer Arbeit, in der die Sicherheit und Durchführbarkeit von Nivolumab in der Neoadjuvanz untersucht wurden.”
BackgroundCheng, X., Huang, J., Li, J., Lu, P., & Luo, Q. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.09.57 · Cited by 1
What the Oncologist Needs From the Pathologist for Immune Therapies
Bernicker, E. (2019) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2019-0340-sa
EGFR and non-small cell lung cancer: implications for surgical practice
Varela, G., & Novoa, N. M. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.04.47
Calin, G., Hofman, P. M., & Mani, S. A. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-452-5
Zheng, Y., Huang, Y., Bian, Y., Du, Y., Lu, T., Sui, Q., Li, M., Chen, Z., Zhan, C., Xi, J., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-3957 · Cited by 1
Immune Dysregulation In Pancreatic Cancer
Huffman, A. P. (2020) · Scholarly Commons (University of Pennsylvania)
Lücke, E., Ganzert, C., Föllner, S., Wäsche, A., Jechorek, D., Schoeder, V., Walles, T., Genseke, P., & Schreiber, J. (2021) · Onkologische Welt · doi:10.1055/a-1402-6818
Liu, J., Tian, S., Ling, Y., Zhang, X., Li, Y., Su, N., & Shi, M. (2021) · Research Square · doi:10.21203/rs.3.rs-528492/v1
Wenleder, S. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8704
Single cell profiling of bronchoalveolar immune cells in checkpoint inhibitor-related pneumonitisPreprint
Cui, P., Li, J., Tao, H., Li, X., Wu, L., Ma, J., Wang, H., Huang, D., Huang, Z., Chen, S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1341170/v1
(2022) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2022.04(04).38
Feng, Y., Sun, W., Zhang, J., Wang, Y., Chen, J., Liu, X., Wang, L., Li, S., Lv, C., Lu, F., et al. (2020) · doi:10.21203/rs.3.rs-23978/v1
Tian, X., Zheng, Q., Tao, Y., Dai, L., Wang, T., & Shen, H. (2020) · doi:10.22541/au.160491626.64176365/v1
Prognostic implication and immunological value of contactin 1 expression in pan‐cancer
Zhang, L., Zhang, J., Liu, T., Zhang, J., & Cui, Y. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.70 · Cited by 1
Shao, W., Xu, Y., Lin, S., Gao, J., Gao, J., & Wang, H. (2022) · Journal of Cancer Science and Clinical Therapeutics · doi:10.26502/jcsct.5079163
Neoadjuvant treatment in non-small-cell lung cancer—the earlier, the better
Terbuch, A., & Absenger, G. (2022) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-022-00828-3
“using two doses of nivolumab before surgical resection [2].”
BackgroundMethod538 Comprehensive single cell transcriptomic profiling of untreated resectable lung cancers
Connor, S. C., Zhang, J., Caushi, J. X., Zhang, B., Zeng, Z., Sanber, K. S., Pereira, G., Anagnostou, V., Tam, A. J., Ionta, N., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-sitc2022.0538
王, 一. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.131139
Wise-Draper, T. M., Gulati, S., Palackdharry, S. M., Hinrichs, B. H., Worden, F. P., Old, M. O., Dunlap, N., Kaczmar, J. M., Patil, Y., Riaz, M. K., et al. (2023) · doi:10.1158/1078-0432.c.6532305.v1
Wang, Y., Luo, M., Chen, Y., Wang, Y., Zhang, B., Ren, Z., Bao, L., Wang, Y., Wang, J. E., Fu, Y., et al. (2023) · doi:10.1158/0008-5472.c.6512614.v1
Data from Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical Oncology
Pourmaleki, M., Socci, N. D., Hollmann, T. J., & Mellinghoff, I. K. (2023) · doi:10.1158/2159-8290.c.6534679
Liu, Q., Zhang, C., Huang, Y., Huang, R., Huang, S. M., Larkins, E. A., Stapleford, L., Rivera, D. R. R., Kluetz, P. G., Wang, S., et al. (2023) · doi:10.1158/2767-9764.c.6551213
Liu, Q., Zhang, C., Huang, Y., Huang, R., Huang, S. M., Larkins, E. A., Stapleford, L., Rivera, D. R. R., Kluetz, P. G., Wang, S., et al. (2023) · doi:10.1158/2767-9764.c.6551213.v1
Data from Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical Oncology
Pourmaleki, M., Socci, N. D., Hollmann, T. J., & Mellinghoff, I. K. (2023) · doi:10.1158/2159-8290.c.6534679.v2
งามโชควัฒนา, ช., วินะยานุวัติคุณ, ช., & จันทรานุวัฒน์, ป. (2022) · Chula Digiverse · doi:10.58837/chula.the.2022.1021
Zeng, Z., Connor, S. C., Zhang, J., Zhan, W., Ji, H., Pardoll, D. M., & Smith, K. N. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-sitc2023.1039
The role of immunotherapy in neoadjuvant treatment of non-small cell lung cancer—a narrative review
Seiwerth, F., Bitar, L., Knežević, J., Madžarac, G., Samaržija, M., & Jakopović, M. (2023) · AME Surgical Journal · doi:10.21037/asj-23-15
Immunotherapy and multimodality therapy for lung cancer
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4429-7
Yu, F., Huang, X., Zhou, D., Zhao, Z., Wu, F., Qian, B., Wang, Q., Chen, J., Liang, Q., Jiang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22611460
Yu, F., Huang, X., Zhou, D., Zhao, Z., Wu, F., Qian, B., Wang, Q., Chen, J., Liang, Q., Jiang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22611454
Yu, F., Huang, X., Zhou, D., Zhao, Z., Wu, F., Qian, B., Wang, Q., Chen, J., Liang, Q., Jiang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22611463
Yu, F., Huang, X., Zhou, D., Zhao, Z., Wu, F., Qian, B., Wang, Q., Chen, J., Liang, Q., Jiang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22611469
Yu, F., Huang, X., Zhou, D., Zhao, Z., Wu, F., Qian, B., Wang, Q., Chen, J., Liang, Q., Jiang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22611466
Yu, F., Huang, X., Zhou, D., Zhao, Z., Wu, F., Qian, B., Wang, Q., Chen, J., Liang, Q., Jiang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22611472
Yu, F., Huang, X., Zhou, D., Zhao, Z., Wu, F., Qian, B., Wang, Q., Chen, J., Liang, Q., Jiang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22611457
Zhou, G., & Li, Q. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i11.1967
Advances and Ongoing Challenges in the Prevention and Control of Lung Cancer
Green, S., O’Hannigan, F., & O’Callaghan, D. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00237-4
Biomarkers for response to immune checkpoint inhibitors in metastatic melanoma
Wind, T. T. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.1065420649
Parks, O. B., Eddens, T. J., Sojati, J., Lan, J., Zhang, Y., Oury, T. D., Ramsey, M. J., Erickson, J. J., Byersdorfer, C. A., & Williams, J. V. (2023) · Figshare · doi:10.6084/m9.figshare.23820039
Parks, O. B., Eddens, T. J., Sojati, J., Lan, J., Zhang, Y., Oury, T. D., Ramsey, M. J., Erickson, J. J., Byersdorfer, C. A., & Williams, J. V. (2023) · Figshare · doi:10.6084/m9.figshare.23820051
Parks, O. B., Eddens, T. J., Sojati, J., Lan, J., Zhang, Y., Oury, T. D., Ramsey, M. J., Erickson, J. J., Byersdorfer, C. A., & Williams, J. V. (2023) · Figshare · doi:10.6084/m9.figshare.23820045
Parks, O. B., Eddens, T. J., Sojati, J., Lan, J., Zhang, Y., Oury, T. D., Ramsey, M. J., Erickson, J. J., Byersdorfer, C. A., & Williams, J. V. (2023) · Figshare · doi:10.6084/m9.figshare.23820036
Parks, O. B., Eddens, T. J., Sojati, J., Lan, J., Zhang, Y., Oury, T. D., Ramsey, M. J., Erickson, J. J., Byersdorfer, C. A., & Williams, J. V. (2023) · Figshare · doi:10.6084/m9.figshare.23820030
Ren, Q., Li, Q., Shao, C., Zhang, P., Hu, Z., Li, J., Wang, W., & Yu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24187825
Parks, O. B., Eddens, T. J., Sojati, J., Lan, J., Zhang, Y., Oury, T. D., Ramsey, M. J., Erickson, J. J., Byersdorfer, C. A., & Williams, J. V. (2023) · Figshare · doi:10.6084/m9.figshare.23820042
Yang, G., Su, X., Huang, Y., Luo, G., Wang, Z., 蔡培强, Zheng, Y., Bei, T., Huang, M., Bai, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26599447
Ren, Q., Li, Q., Shao, C., Zhang, P., Hu, Z., Li, J., Wang, W., & Yu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24187831
Yu, F., Huang, X., Zhou, D., Zhao, Z., Wu, F., Qian, B., Wang, Q., Chen, J., Liang, Q., Jiang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22611475
Ren, Q., Li, Q., Shao, C., Zhang, P., Hu, Z., Li, J., Wang, W., & Yu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24187828
Parks, O. B., Eddens, T. J., Sojati, J., Lan, J., Zhang, Y., Oury, T. D., Ramsey, M. J., Erickson, J. J., Byersdorfer, C. A., & Williams, J. V. (2023) · Figshare · doi:10.6084/m9.figshare.23820033
Yu, F., Huang, X., Zhou, D., Zhao, Z., Wu, F., Qian, B., Wang, Q., Chen, J., Liang, Q., Jiang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22611478
Ren, Q., Li, Q., Shao, C., Zhang, P., Hu, Z., Li, J., Wang, W., & Yu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24187834
Parks, O. B., Eddens, T. J., Sojati, J., Lan, J., Zhang, Y., Oury, T. D., Ramsey, M. J., Erickson, J. J., Byersdorfer, C. A., & Williams, J. V. (2023) · Figshare · doi:10.6084/m9.figshare.23820048
Exploring the impact of probiotics and tumor-resident commensal bacteria on cancer
McPherson, A. C. (2024) · D-Scholarship@Pitt (University of Pittsburgh)
Dahan, M. (2023) · theses.fr (ABES) · doi:10.70675/ba071bbczf50bz4de2za53ez46adb6d11631
Radiothérapie et Immunothérapie : le micro-environnement au cœur de leur synergie
Gauthier, A. (2023) · theses.fr (ABES) · doi:10.70675/0e169791zfaeaz43c3zbb40z7cc64adf47f9
Fan, X., Zhang, M., Dq, X., Chen, R., Qian, L. L., Zhu, J., & Li, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-63405-2
Kurt, S., & Krishnamurthy, K. (2026) · Pathology International · doi:10.1111/pin.70183
Li, H., Li, B., Li, Z., Wang, Z., Sun, W., Yang, K., Yang, Y., & Wang, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1956181
Metadata
- Authors
- Yang, X., Yin, R., & Xu, L.
- Affiliations
- The First People's Hospital of Changzhou (CN)
- Jiangsu Cancer Hospital (CN)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-08-30
- Volume
- 379
- Issue
- 9
- Pages
- e14-e14
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2982617740
- Cited by
- 277
- References
- 8
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 25 · 2023: 65 · 2022: 40 · 2021: 49 · 2020: 49 · 2019: 28 · 2018: 7
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Keywords
- neoadjuvant immunotherapy, anti-PD-1 therapy, lung cancer, resectable non-small cell lung cancer, immune checkpoint inhibitors, surgical resection
- MeSH terms
- Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Pancreatic Neoplasms, Neoadjuvant Therapy, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.